Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Omega Fund Management, LLC (CIK 1637359) reported $163.1M across 9 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: BCAX ($47.6M, 29.16%), NUVB ($34.7M, 21.25%), ($29.4M, 18.05%), KMTS ($20.4M, 12.49%), BBNX ($13.2M, 8.08%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BCAX | Bicara Therapeutics Inc. | $47.6M | 29.16% | 2.4M | Added |
| 2 | NUVB | Nuvation Bio Inc. | $34.7M | 21.25% | 8.1M | Hold |
| 3 | BridgeBio Oncology Therapeutics Inc. | $29.4M | 18.05% | 3.3M | Hold | |
| 4 | KMTS | Kestra Med Technologies Ltd | $20.4M | 12.49% | 1.0M | Trimmed |
| 5 | BBNX | Beta Bionics Inc. | $13.2M | 8.08% | 1.3M | Hold |
| 6 | ENGN | enGene Holdings Inc. | $6.0M | 3.66% | 876,357 | Hold |
| 7 | ALMS | Alumis Inc. | $5.3M | 3.26% | 241,255 | Trimmed |
| 8 | SANA | Sana Biotechnology, Inc. | $2.4M | 1.49% | 843,750 | Hold |
| 9 | IKNA | ImageneBio, Inc. | $2.3M | 1.40% | 455,361 | Hold |
| 10 | REPL | Replimune Group | $1.9M | 1.17% | 248,672 | Hold |
| 11 | UPB | Upstream Bio Inc. | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31